The Silent Crisis: When You Cannot Feel the Danger
There is a particular kind of medical irony in diabetic foot pathology. The wound that can end in amputation frequently begins with no pain at all. The very diabetic nerve damage that prevents a person with diabetes from feeling a blister, a friction point, or a foreign object in their shoe is the same damage that allows a minor wound to progress into a Grade 3 ulcer over a period of days—entirely undetected.
This is the clinical reality of diabetic peripheral neuropathy: a progressive, length-dependent nerve damage that begins at the tips of the longest nerves—the feet—and advances proximally. It affects approximately 50% of people who have had diabetes for 20 or more years, and its presence multiplies the lifetime risk of a neuropathy foot ulcer sevenfold.
Three Types of Neuropathy in Diabetic Foot Disease
1. Peripheral Sensory Neuropathy
The most clinically significant neuropathy type for foot ulcer risk. Damage to sensory nerve fibres causes foot sensation loss, eliminating protective pain sensation—the body’s primary early warning system against injury. Patients cannot feel cuts, pressure, temperature extremes, or the progressive skin breakdown that occurs under an ill-fitting shoe.
2. Peripheral Motor Neuropathy
Motor nerve damage causes atrophy of the intrinsic foot muscles, leading to characteristic foot deformities—claw toes, hammer toes, prominent metatarsal heads, and Charcot foot. These deformities concentrate pressure at abnormal plantar sites, dramatically increasing the risk of ulceration at the ball of the foot and toe tips.
3. Autonomic Neuropathy
Autonomic nerve damage disrupts sweat and oil gland function in the foot, causing skin to become excessively dry, cracked, and fissured—creating entry points for bacteria. It also causes arteriovenous shunting (blood bypassing capillaries), which is paradoxically associated with warm, bounding pulses and dry skin despite underlying vascular compromise.
The 10-Gram Monofilament Test: India's Most Under-Used Diagnostic Tool
The Semmes-Weinstein 10-gram monofilament test is a simple, inexpensive neuropathy screening test that should be performed at every diabetes review. The monofilament is pressed against standardised plantar sites until it buckles—delivering a calibrated 10-gram force. If the patient cannot feel this at any of the test sites, protective sensation is clinically absent, and the foot is at significant ulcer risk.
In India, this test is severely underutilised in primary care settings. A 2024 review of diabetic foot management in Indian tertiary hospitals found that fewer than 30% of patients with documented neuropathy had received formal monofilament testing in the preceding year. This represents one of the most impactful—and correctable—gaps in India’s diabetic foot care pathway.
How Neuropathy Creates the Wound That Doesn't Hurt?
Understanding the wound-creation pathway helps patients and caregivers intervene at the earliest possible stage:
- Sensory loss: Because of foot sensation loss, a tight shoe seam, a small stone in the shoe, or a floor tile creates repetitive focal pressure on the plantar foot. Because pain sensation is absent, the patient does not react.
- Tissue breakdown: Prolonged pressure and friction create a callus. Beneath the callus, haemorrhage and tissue necrosis begin, concealed by the thickened skin layer.
- Wound formation: The callus is removed (either during hygiene or self-treatment), revealing a neuropathy foot ulcer — often already infected.
- Infection and escalation: With immune suppression from hyperglycaemia and poor circulation limiting antibiotic delivery, the infection advances rapidly to bone (osteomyelitis) or spreads to surrounding tissue.
- Amputation risk: By the time many Indian patients reach secondary care, they already have Wagner Grade 3+ wounds requiring surgical intervention.
What Neuropathy Treatment Can and Cannot Do?
This is an area requiring honest nuance. No currently approved medication reverses established diabetic nerve damage. The primary goal of neuropathy treatment is slowing progression through rigorous glycaemic control (HbA1c < 8%) and addressing modifiable risk factors. Symptomatic treatment for painful neuropathy includes:
- Pregabalin and gabapentin: First-line agents for neuropathic pain management (ADA Standards of Care 2024)
- Duloxetine: FDA-approved for diabetic peripheral neuropathy pain; also provides mood support in patients with depression comorbidity
- Topical capsaicin/lidocaine patches: Useful adjuncts for localised painful neuropathy
- Alpha-lipoic acid: An antioxidant with moderate evidence for improving neuropathy symptoms; widely used in India; 600 mg/day IV formulation used in clinical settings
Key Insight: Paradoxically, painful neuropathy—often considered worse than painless neuropathy—actually carries a LOWER amputation risk. Pain signals that something is wrong; foot sensation loss allows wounds to develop undetected. Absence of pain is not a reassurance.
Daily Foot Protection Protocol for Neuropathic Patients
- Inspect both feet every morning in good light—use a mirror for the sole. Check between toes.
- Wear well-fitted, closed-toe shoes at all times—including at home, to prevent a neuropathy foot ulcer. Diabetic therapeutic footwear is available in India from specialist orthotics providers.
- Check shoes for debris, seams, or foreign objects before wearing.
- Wear moisture-wicking diabetic socks without tight elastic bands.
- Test bath water temperature with your elbow, not your foot, before bathing.
- Never use hot water bottles, electric blankets, or heating pads on neuropathic feet.
- Attend formal podiatry review every 3 months for neuropathy treatment assessment.
Protect neuropathic feet with Cimidaxil’s preventive foot care and early wound management solutions.
FAQs: Neuropathy and Foot Ulcers
1. Can diabetic neuropathy be reversed?
Established diabetic nerve damage cannot currently be reversed. However, early intervention—tightly controlling blood glucose before significant nerve damage occurs—is highly effective at preventing progression. Some early sensory loss may partially recover with sustained glycaemic optimisation over 12–24 months
2. How do I know if I have neuropathy if I have no symptoms?
This is the clinical paradox of painless neuropathy. Screening with the 10-gram monofilament test is the most reliable detection method. If your diabetes team has not performed this test in the last 12 months, request it at your next review. Also test vibration sensation (128 Hz tuning fork at the first metatarsal head) and ankle reflexes.
3. Does walking cause foot ulcers in neuropathic patients?
Walking itself does not cause ulcers, but walking without appropriate footwear on deformed feet creates repetitive mechanical trauma that, combined with sensory loss, leads to ulceration. Therapeutic footwear and custom orthotics that redistribute plantar pressure are the most evidence-supported interventions for diabetic foot.